Aug 4, 2026 08:01AM
Apr 7, 2026 08:07AM
Mar 26, 2026 08:02AM
Mar 16, 2026 08:02AM
Nov 19, 2025 08:01AM
May 29, 2025 08:04AM
May 19, 2025 08:03AM Alzamend Neuro (ALZN) Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study
May 8, 2025 08:01AM
Mar 27, 2025 04:35PM
Mar 4, 2025 08:11AM
Feb 19, 2025 08:04AM
Nov 19, 2024 08:02AM
Oct 16, 2024 08:06AM
Oct 15, 2024 08:04AM Alzamend Neuro (ALZN) Regains Compliance with Nasdaq Listing Standards
Aug 26, 2024 08:04AM
Aug 19, 2024 10:03AM
Aug 19, 2024 08:06AM
Aug 12, 2024 08:03AM
Aug 5, 2024 09:10AM
Jul 31, 2024 08:00AM
Jul 12, 2024 08:00AM Alzamend Neuro (ALZN) Announces 1:10 Reverse Share Split
Jun 26, 2024 04:48PM

443,917 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All